Chemoinformaics analysis of 3,4-dihydroxyphenylethanol
| Molecular Weight | 154.165 | nRot | 2 |
| Heavy Atom Molecular Weight | 144.085 | nRig | 6 |
| Exact Molecular Weight | 154.063 | nRing | 1 |
| Solubility: LogS | 0.151 | nHRing | 0 |
| Solubility: LogP | 0.174 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 21 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 22.4339 |
| nHD | 3 | BPOL | 10.0321 |
| QED | 0.547 |
| Synth | 1.936 |
| Natural Product Likeliness | 1.193 |
| NR-PPAR-gamma | 0.014 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.002 |
| HIA | 0.839 |
| CACO-2 | -4.433 |
| MDCK | 0.0000122 |
| BBB | 0.037 |
| PPB | 0.355326 |
| VDSS | 1.129 |
| FU | 0.613171 |
| CYP1A2-inh | 0.247 |
| CYP1A2-sub | 0.367 |
| CYP2c19-inh | 0.066 |
| CYP2c19-sub | 0.074 |
| CYP2c9-inh | 0.048 |
| CYP2c9-sub | 0.805 |
| CYP2d6-inh | 0.075 |
| CYP2d6-sub | 0.602 |
| CYP3a4-inh | 0.062 |
| CYP3a4-sub | 0.18 |
| CL | 17.222 |
| T12 | 0.912 |
| hERG | 0.022 |
| Ames | 0.687 |
| ROA | 0.105 |
| SkinSen | 0.937 |
| Carcinogencity | 0.39 |
| EI | 0.986 |
| Respiratory | 0.074 |
| NR-Aromatase | 0.032 |
| Antiviral | No |
| Prediction | 0.893492 |